Multimodal low-opioid anesthesia as a factor in reducing the activation of the proinflammatory response in cardiac surgery

S.R. Maruniak, O.A. Loskutov, O.M. Druzhyna I.R. Malysh, V.G. Kolesnikov, N.O. Korotchuk

References 

1. Barbarash LS, Grigoryev EV, Plotnikov GP, et al. Multiple organ failure after cardiosurgical interventions. General Reanimatology.2010;6:31–34. (In Russ.).
2. Gandzyuk VA. Analysis of ischemic heart disease morbidity in Ukraine. Ukr. J. Cardiol. 2014;3:45–52. (In Ukr.).
3. Bronicki RA, Hall M. Cardiopulmonary Bypass-Induced Inflammatory Response: Pathophysiology and Treatment. Pediatr Crit Care Med. 2016;17 (Suppl. 1):S272–278. doi:10.1097/PCC.0000000000000759.
4. Butcher SK, Lord JM. Stress responses and innate immunity: aging as a contributory factor. Aging Cell. 2004;3:151–160. doi: 10.1111/j.1474-9728.2004.00103.x.
5. Corral-Velez V, Lopez-Delgado JC, Betancur-Zambrano NL, Lopez-Suñe N, Rojas-Lora M, Torrado H, Ballus J. The inflammatory response in cardiac surgery: an overview of the pathophysiology and clinical implications. Inflamm Allergy Drug Targets. 2015;13 (6):367–370. doi: 10.2174/1871528114666150529120801.
6. De Gennaro L, Brunetti ND, Montrone D, De Rosa F, Cuculo A, Di Biase M. Subacute inflammatory activation in subjects with acute coronary syndrome and left ventricular dysfunction. Inflammation. 2012;35:363–370. doi: 10.1007/s10753-011-9326-4.
7. Hernandez A, Shaw AD. Age and inflammation after cardiac surgery. Brit. J. Anaesthesia. 2017;119 (4):562–563. doi: 10.1093/bja/aex275.
8. Li B, Li Y, Tian S. Li B, Li Y, Tian S, Wang H, Wu H, Zhang A, Gao C. Anti-inflammatory effects of perioperative dexmedetomidine administered as an adjunct to general anesthesia: a meta-analysis. Sci Rep. 2015;21:12342. doi: 10.1038/srep12342.
9. Luggya TS, Roche T, Ssemogerere L, Kintu A, Kasumba JM, Kwizera A, Tindimwebwa JV. Effect of low-dose ketamine on post-operative serum ІЛ-6 production among elective surgical patients: a randomized clinical trial. Afr. Health Sci. 2017;17 (2):500–507. doi: 10.4314/ahs.v17i2.25.
10. Mazzone A, , De Servi S, Vezzoli M, Fossati G, Mazzucchelli I, Gritti D, Ottini E, Mussini A, Specchia G. Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis. 1999;145:369–374. doi: 10.1016/s0021-9150(99)00104-5.
11. Mozaffarian D, Benjamin EJ, Go AS. et al. Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation. 2015;131:e29–e322. doi:10.1161/CIR.0000000000000152.
12. Negwera MN, Georgiev SJ, Penev AP. Cytokine Interleukin-6 in patients with paroxysmal atrial fibrillation. Int J Pharm Med. Res. 2015;3:16–20.
13. Oliveira C.M. Barros de, Sakata R.K, Slullitel A, Salomão R, Lanchote VL, Issy AM. Effect of intraoperative intravenous lidocaine on pain and plasma interleukin-6 in patients undergoing hysterectomy. Rev Bras Anestesiol. 2015;65 (2):92–98. doi: 10.1016/j.bjan.2013.07.017.
14. Rong LQ, Kamel MK, Rahouma M, Naik A, Mehta K, Abouarab AA, Di Franco A, Demetres M, Mustapich TL, Fitzgerald MM, Pryor KO, Gaudino M. High-dose versus low-dose opioid anesthesia in adult cardiac surgery: A meta-analysis. J Clin Anesth. 2019;57:57–62. doi: 10.1016/j.jclinane.2019.03.009.
15. Rus H, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerostic all. Atherosclerosis. 1996;127:263–271. doi: 10.1016/s0021-9150(96)05968-0.